About this Research Topic
As the population ages, the prevalence of diabetes, immunosuppressive agent use, and the incidence of AIDS in recent years have brought infectious diseases into sharp focus across various medical disciplines, including dermatology. The unique structural and functional characteristics of the skin make it increasingly susceptible to a wide range of infections. This not only includes common infections like viruses, bacteria, and fungi but also highlights the growing importance of rare pathogenic infections. Some previously controlled infectious skin diseases, such as tuberculosis and leprosy, have seen resurgences, becoming highly infectious or experiencing regional outbreaks, often accompanied by significant mortality and disability rates. Notably, newly emerging skin diseases related to conditions like COVID-19, monkeypox, ear candidiasis (super fungus), aspergillosis, Talaromyces marneffei, sporotrichosis, and cryptococcosis require heightened attention. It is imperative to better understand the epidemiological trends, unique clinical presentations, the latest pathogenesis research, and the emergence of drug-resistant strains associated with these diseases.
This research aims to elucidate the epidemiological trends, distinct clinical manifestations, recent advances in pathogenesis research, and the emergence of drug-resistant strains associated with infectious skin diseases. The goal is to provide guidance for monitoring drug-resistant infections and to propose targeted prevention and control measures, thereby informing clinical best practices. Simultaneously, this research also underscores the significance of opportunistic infections resulting from rare pathogens. We invite submissions on all aspects of skin bacterial, fungal, viral and parasitic infections. The scope of topics includes but is not limited to:
• Drug resistance issues concerning dermatophytes.
• Clinical manifestations, epidemiology, and relevant studies on monkeypox.
• Recent developments in epidemiology, pathogenesis, and treatment of sporotrichosis.
• The latest research on leprosy.
• Cutaneous infectious diseases in immunocompromised populations.
• Studies on the follicular occlusion triad.
This research aims to elucidate the epidemiological trends, distinct clinical manifestations, recent advances in pathogenesis research, and the emergence of drug-resistant strains associated with infectious skin diseases. The goal is to provide guidance for monitoring drug-resistant infections and to propose targeted prevention and control measures, thereby informing clinical best practices. Simultaneously, this research also underscores the significance of opportunistic infections resulting from rare pathogens. We invite submissions on all aspects of skin bacterial, fungal, viral and parasitic infections. The scope of topics includes but is not limited to:
• Drug resistance issues concerning dermatophytes.
• Clinical manifestations, epidemiology, and relevant studies on monkeypox.
• Recent developments in epidemiology, pathogenesis, and treatment of sporotrichosis.
• The latest research on leprosy.
• Cutaneous infectious diseases in immunocompromised populations.
• Studies on the follicular occlusion triad.
Keywords: Pathogen, pathogenesis, epidemiology, diagnosis and therapeutic progress
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
